Boston Scientific revenue and financials
$42.19Change from previous close: −0.50%Absolute change: −$0.21
In the fiscal year ended December 2025, Boston Scientific reported revenue of $20.07B (+19.87% year over year). Net income was $2.89B, a net margin of 14.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +19.87%
- 2025 vs 2024
- Net income growth
- +56.66%
- 2025 vs 2024
- Net margin
- 14.4%
- 2024: 11.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 45,216 | 44,351 | 43,673 | 42,707 | 41,559 | 40,140 | 39,395 | 38,078 | 37,108 | 36,669 | 35,136 | 34,043 |
| Current assets | 7,972 | 8,684 | 8,794 | 8,035 | 7,121 | 7,335 | 6,920 | 8,761 | 8,991 | 8,185 | 6,514 | 6,504 |
| Cash and equivalents | 539 | 1,453 | 1,965 | 1,275 | 534 | 725 | 414 | 2,502 | 2,913 | 2,329 | 865 | 952 |
| Receivables | 3,049 | 3,027 | 2,926 | 2,828 | 2,815 | 2,693 | 2,558 | 2,501 | 2,400 | 2,304 | 2,228 | 2,101 |
| Inventory | 3,235 | 3,117 | 2,943 | 2,921 | 2,861 | 2,867 | 2,810 | 2,753 | 2,608 | 2,561 | 2,484 | 2,404 |
| Net property, plant and equipment | 4,679 | 4,610 | 4,501 | 4,290 | 3,953 | 3,837 | 3,743 | 3,498 | 3,367 | 3,327 | 3,298 | 3,081 |
| Goodwill | 18,640 | 18,536 | 18,282 | 18,214 | 18,076 | 17,340 | 17,089 | 15,033 | 14,397 | 14,361 | 14,387 | 13,608 |
| Other intangible assets | 6,918 | 7,060 | 7,019 | 7,162 | 7,260 | 6,566 | 6,684 | 5,758 | 5,430 | 5,861 | 6,003 | 5,889 |
| Long-term investments | 2,245 | 705 | 682 | 642 | 626 | 654 | 555 | 532 | 450 | 429 | 413 | 427 |
| Current liabilities | 6,428 | 4,571 | 5,439 | 5,328 | 5,190 | 5,058 | 6,399 | 5,910 | 5,576 | 4,916 | 4,933 | 4,579 |
| Accounts payable | 1,231 | 1,141 | 1,144 | 1,002 | 962 | 1,004 | 960 | 907 | 906 | 921 | 942 | 929 |
| Long-term debt | 10,791 | 10,864 | 11,012 | 10,992 | 10,981 | 10,406 | 8,842 | 9,229 | 8,987 | 9,530 | 8,566 | 8,382 |
| Total debt | — | 11,029 | 11,436 | 12,046 | 12,027 | 11,708 | — | — | — | — | — | — |
| Total liabilities | 20,044 | 18,247 | 19,201 | 19,077 | 18,906 | 17,695 | 17,392 | 17,122 | 16,499 | 16,501 | 15,606 | 14,914 |
| Total equity (incl. minority) | 25,172 | 26,104 | 24,472 | 23,630 | 22,653 | 22,445 | 22,003 | 20,956 | 20,609 | 20,168 | 19,530 | 19,129 |
| Retained earnings | 7,818 | 6,912 | 5,571 | 4,899 | 4,144 | 3,347 | 2,673 | 2,107 | 1,639 | 1,314 | 819 | 315 |
| Minority interest | 242 | 240 | 239 | 236 | 235 | 233 | 233 | 248 | 238 | 242 | 248 | 243 |